Am J Physiol Cell Physiol Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 285: C922-C934, 2003. First published May 7, 2003; doi:10.1152/ajpcell.00115.2003
0363-6143/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/4/C922    most recent
00115.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adarichev, V. A.
Right arrow Articles by Voyno-Yasenetskaya, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adarichev, V. A.
Right arrow Articles by Voyno-Yasenetskaya, T. A.

GROWTH, DIFFERENTIATION, AND APOPTOSIS

G{alpha}13-mediated transformation and apoptosis are permissively dependent on basal ERK activity

Vyacheslav A. Adarichev, Rita Vaiskunaite, Jiaxin Niu, Irina V. Balyasnikova, and Tatyana A. Voyno-Yasenetskaya

Departments of Pharmacology and Anesthesiology, University of Illinois, Chicago, Illinois 60612

Submitted 25 March 2003 ; accepted in final form 1 May 2003

We previously reported that the {alpha}-subunit of heterotrimeric G13 protein induces either mitogenesis and neoplastic transformation or apoptosis in a cell-dependent manner. Here, we analyzed which signaling pathways are required for G{alpha}13-induced mitogenesis or apoptosis using a novel mutant of G{alpha}13. We have identified that in human cell line LoVo, the mutation encoding substitution of Arg260 to stop codon in mRNA of G{alpha}13 subunit produced a mutant protein (G{alpha}13-T) that lacks a COOH terminus and is endogenously expressed in LoVo cells as a polypeptide of 30 kDa. We found that G{alpha}13-T lost its ability to promote proliferation and transformation but retained its ability to induce apoptosis. We found that full-length G{alpha}13 could stimulate Elk1 transcription factor, whereas truncated G{alpha}13 lost this ability. G{alpha}13-dependent stimulation of Elk1 was inhibited by dominant-negative extracellular signal-regulated kinase (MEK) but not by dominant-negative MEKK1. Similarly, MEK inhibitor PD-98059 blocked G{alpha}13-induced Elk1 stimulation, whereas JNK inhibitor SB-203580 was ineffective. In Rat-1 fibroblasts, G{alpha}13-induced cell proliferation and foci formation were also inhibited by dominant-negative MEK and PD-98059 but not by dominant-negative MEKK1 and SB-203580. Whereas G{alpha}13-T alone did not induce transformation, coexpression with constitutively active MEK partially restored its ability to transform Rat-1 cells. Importantly, full-length but not G{alpha}13-T could stimulate Src kinase activity. Moreover, G{alpha}13-dependent stimulation of Elk1, cell proliferation, and foci formation were inhibited by tyrosine kinase inhibitor, genistein, or by dominant-negative Src kinase, suggesting the involvement of a Src-dependent pathway in the G{alpha}13-mediated cell proliferation and transformation. Importantly, truncated G{alpha}13 retained its ability to stimulate apoptosis signal-regulated kinase ASK1 and c-Jun terminal kinase, JNK. Interestingly, the apoptosis induced by G{alpha}13-T was inhibited by dominant-negative ASK1 or by SB-203580.

mitogen-activated kinase; effector mutant; Src kinase



Address for reprint requests and other correspondence: T. Voyno-Yasenetskaya, Dept. of Pharmacology, College of Medicine, Univ. of Illinois, 835 South Wolcott Ave., Chicago, IL 60612 (E-mail: tvy{at}uic.edu).




This article has been cited by other articles:


Home page
FASEB J.Home page
M. A. Kutuzov, A. V. Andreeva, and T. A. Voyno-Yasenetskaya
Regulation of apoptosis signal-regulating kinase 1 degradation by G{alpha}13
FASEB J, November 1, 2007; 21(13): 3727 - 3736.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Kim, J. Jin, and S. P. Kunapuli
Relative contribution of G-protein-coupled pathways to protease-activated receptor-mediated Akt phosphorylation in platelets
Blood, February 1, 2006; 107(3): 947 - 954.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Liu and T. A. Voyno-Yasenetskaya
Radixin Stimulates Rac1 and Ca2+/Calmodulin-dependent Kinase, CaMKII: CROSS-TALK WITH G{alpha}13 SIGNALING
J. Biol. Chem., November 25, 2005; 280(47): 39042 - 39049.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
I. Tegeder and G. Geisslinger
Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications
Pharmacol. Rev., September 1, 2004; 56(3): 351 - 369.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.